Amnon Peled
38Patents
6h-index
17Co-inventors
66Inventor score
Filing activity: Aug 5, 1991 → Dec 13, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8455450B2 | Methods for obtaining a therapeutically effective amount of hematopoietic precursor cells and long term engraftment thereof | Human Necessities | 14 | Active |
| US10682390B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 11 | Active |
| US7101708B1 | Hematopoietic cell composition for use in transplantation | Chemistry; Metallurgy | 11 | Expired |
| US10786547B2 | Compositions, articles of manufacture and methods for treating cancer | Chemistry; Metallurgy | 11 | Active |
| US9493557B2 | Chemokine binding polypeptides for treating autoimmunity and inflammation | Chemistry; Metallurgy | 7 | Active |
| US10646465B2 | Small molecules against cancer | Emerging Cross-Sectional Technologies | 6 | Active |
| US5155001A | Liquid developer method with replenishment of charge director | Physics | 6 | Expired |
| US11129824B2 | Small molecules for inhibiting chemokine activity and/or cancer cells growth | Emerging Cross-Sectional Technologies | 4 | Active |
| US8383769B2 | Peptides for inhibiting chemokine binding to chemokine receptors | Human Necessities | 3 | Active |
| US11261159B2 | Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death | Human Necessities | 3 | Active |
| US8039440B2 | Peptides for inhibiting chemokine binding to chemokine receptors | Human Necessities | 2 | Active |
| US9034814B2 | CXCR4 antagonists for wound healing and re-epithelialization | Chemistry; Metallurgy | 2 | Active |
| US11534478B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US9439942B2 | Peptides and use thereof in the treatment of large cell lung cancer | Human Necessities | 1 | Active |
| US11559562B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US11590200B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US11612638B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US11554159B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US11780814B2 | Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death | Human Necessities | 1 | Active |
| US11607444B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US11648293B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US8765683B2 | T-140 peptide analogs having CXCR4 super-agonist activity for cancer therapy | Human Necessities | 1 | Active |
| US11642393B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US11638743B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US11638742B2 | Compositions and methods for treating cancer | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.